Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats

Journal of Physiology Paris

Volumn 93, Issue 6, 1999, Pages 467-477

  Sikiric, Predrag ^a   Jadrijevic, Stipislav ^a   Seiwerth, Sven ^a   Sosa, Tomislav ^a   Deskovic, Slobodan ^a   Perovic, Darko ^a   Aralica, Gorana ^a   Grabarevic, Zeljko ^a   Rucman, Rudolf ^a   Petek, Marijan ^a   Jagic, Vjekoslav ^a   Turkovic, Branko ^a   Ziger, Tomislav ^a   Rotkvic, Ivo ^a   Mise, Stjepan ^a   Zoricic, Ivan ^a   Sebecic, Božidar ^a   Patrlj, Leonardo ^a   Kocman, Boris ^a   Sarlija, Marko ^a   Mikus, Darko ^a   Šeparovic, Jadranka ^a   Hanzevacki, Miroslav ^a   Gjurašin, Miroslav ^a   Miklic, Pavle ^a   Buljat, Gojko ^a   more..

^a University of Zagreb Faculty of Veterinary Medicine   (Croatia)

Author keywords

Anti ulcer agents; Long lasting cytoprotection; Pentadecapeptide BPC 157; Rats; Reflux oesophagitis

Indexed keywords

ANTIULCER AGENT; COLESTYRAMINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; RANITIDINE; SUCRALFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; FEMALE; INFLAMMATORY CELL; NONHUMAN; POLYMORPHONUCLEAR CELL; RAT; REFLUX ESOPHAGITIS;

EID: 0033402464     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(99)00124-2     Document Type: Conference Paper

References (49)

1. Axelson J., Persson P., Gagnemo-Persson R., Hakanson R. Importance of the stomach in maintaining calcium homoeostasis in the rat. Gut. 32:1991;1298-1302.
2. Bodis B., Karadi O., Nagy L., Dohoczky Cs., Kolega M., Mozsik Gy. Direct cellular effects of some mediators, hormones and growth factor-like agents on denervated (isolated) rat gastric mucosal cells. J. Physiol. (Paris). 91:1997;183-187.
3. Bosnjak Z.J., Graf B.M., Sikiric P. Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J. 8:1994;A129.
4. Clissold S.P., Campoli-Richards D.M. Omeprazole. An updated review. Drugs. 32:1986;15-47.
5. Dajani E.Z. Prostaglandins and the integrity of the esophageal mucosa. Scarpignato C. Advances in Drug Therapy of Gastroesophageal Reflux Disease. Front. Gastrointest. Res. vol. 20:1992;307-316 Karger, Basel.
6. Damman H.G. Treatment of gastroesophageal reflux disease with ranitidine. Scarpignato C. Advances in Drug Therapy of Gastroesophageal Reflux Disease. Front. Gastrointest. Res. vol. 20:1992;208-230 Karger, Basel.
7. Dawson-Saunders B., Trapp R.G. Basic and Clinical Biostatistics. 2nd :1994;Appleton and Lange, East Norwalk.
8. Erceg D., Simicevic V.N., Kolega M., Dohoczky C. Some aspects of PL-10. 1. AK-15 on the gastrointestinal tract. J. Physiol. (Paris). 91:1997;179-181.
9. Grabarevic Z., Tisljar M., Artukovic B., Bratulic M., Dzaja P., Seiwerth S., Sikiric P., Peric J., Geres D., Kos J. The influence of BPC 157 on nitric-oxyde agonists and antagonist induced lesions in broiler chicks. J. Physiol. (Paris). 91:1997;139-150.
10. Guglietta A. Possible clinical use of peptide growth factors in the GI tract: perspectives and obstacles. Exp. Clin. Gastroenterol. 3:1992;1-6.
11. Heading R.C., Eaves N.R. Aims of treatment in gastroesophageal reflux disease. Scarpignato C. Advances in Drug Therapy of Gastroesophageal Reflux Disease. Front. Gastrointest. Res. vol. 20:1992;1-10 Karger, Basel.
12. Ishii Y., Fujii Y., Yamashita T. Effect of sodium polyacrylate on chronic reflux esophagitis in rats. Arzneim. Forsch./Drug Res. 31:1981;212-215.
13. Jelovac N., Sikiric P., Rucman R., Petek M., Perovic D., Konjevoda P., Marovic A., Seiwerth S., Grabarevic Z., Sumajstorcic J., Dodig G. A novel pentadecapeptide BPC 157 blocks the stereotype produced acutely by amphetamine and the developement of haloperidol-induced supersensitivity to amphetamine. Biol. Psych. 43:1998;511-519.
14. Kalogjera L., Ries N., Baudoin T., Ferencic Z., Protic R., Pegan B. Dose dependent protective effect of BPC 157 in capsaicin induced rhinitis in rats. Eur. Arch. Otorhynolaringol. 254:1997;S9-S11.
15. Konjevoda P., Nasic M., Curkovic T., Sikiric P., Seiwerth S., Stambuk N. Effects of BPC 157 on the healing of corneal lesions. Ohno S, Aoki K, Usui M, Uchio E. Uveitis Today. 1998;311-314 Elsevier, Amsterdam.
16. Konturek S.J., Brzozowski T., Konturek P., Ostrowski J. Polyamines in the EGF and TGFα-induced gastric acid inhibition, gastroprotection and gastric adaptation to topical irritants. Digestion. 55 (S2):1994;21.
17. Paré W., Kluczynski J.M. The effect of new gastric juice peptide BPC on classic stress trial in stress procedure. Exp. Clin. Gastroenterol. 2:1994;234-236.
18. Robert A. Cytoptotection by prostaglandins. Gastroenterology. 77:1979;761-767.
19. Robert A., Lancaster C., Olafsson A.S., Gilbertson-Beadling S., Zhang W. Gastric adaptation to the ulcerogenic effect of aspirin. Exp. Clin. Gastroenterol. 1:1992;73-81.
20. Rourk R.M., Namiot Z., Sarosiek J., Yu Z., McCallum R.W. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis. Am. J. Gastroenterol. 89:1994;237-244.
21. Salmon R., Heim B. Bile reflux esophagitis. A critical study of two models in the rat. Digestion. 22:1981;73-79.
22. Sandor Z., Vincze A., Szabo S. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J. 10:1996;171.
23. Sandor Z., Vincze A., Jadus M.R., Dohocky C., Erceg D., Brajsa K., Kolega M., Szabo S. The protective effect of newly isolated peptide PL-10 in the iodoacetamide colitis model in rats. Gastroenterology. 112:1997;400.
24. Scalabrino G., Monzio-Compagnoni B., Ferioli M.E., Lorenzini E.C., Chiodini E., Candiani R. Subacute combined degeneration and induction of ornithine decarboxylase in spinal cords of totally gastrectomized rats. Lab. Inv. 62:1990;297-304.
25. Seiwerth S., Sikiric P., Grabarevic Z., Zoricic I., Hanzevacki M., Ljubanovic D., Coric V., Konjevoda P., Petek M., Rucman R., Turkovic B., Perovic D., Mikus D., Jadrijevic S., Medvidovic M., Tadic T., Romac B., Kos J., Peric J., Kolega Z. BPC 157 effect on healing. J. Physiol. (Paris). 91:1997;173-178.
26. Seto Y., Kobori O. Role of reflux esophagitis and acid in the development of columnar epithelium in the rat oesophagus. Br. J. Surg. 80:1981;467-470.
27. Sikiric P., Banic M., Brkic T., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Anic B., Rotkvic I., Duvnjak M., Veljaca M., Simicevic V. Effect of a novel pentadecapeptide BPC 157 and methylprednisolone in a murine model of inflammatory bowel disease. Gastroenterology. 104:1993;782.
28. Sikiric P., Gyires K., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Rotkvic I., Turkovic B., Udovicic I., Jagic V., Mildner B., Duvnjak M., Danilovic Z. The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity. Inflammopharmacology. 2:1993;121-127.
29. Sikiric P., Petek M., Rucman R., Seiwerth S., Grabarevic Z., Rotkvic I., Turkovic B., Jagic V., Mildner B., Duvnjak M., Lang N. A new gastric juice peptide BPC - an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects. J. Physiol. (Paris). 87:1993;313-327.
30. 4 application. A comparative study with dopamine agonists and somatostatin. Life Sci. 53:1993;PL291-PL296.
31. 2 receptor antagonists, dopamine promotors and gut peptides. Life Sci. 54:1994;PL63-PL68.
32. Sikiric P., Rotkvic I., Mise S., Seiwerth S., Grabarevic Z., Petek M., Rucman R., Zjacic-Rotkvic V., Duvnjak M., Jagic V., Suchanek E., Marovic A., Banic M., Brkic T., Hanzevacki M., Separovic J., Djacic S., Simicevic V. Dopamine agents efficacy in peptic ulcer healing and relapse prevention - a further indication for importance of stomach dopamine in the stress organoprotection concept. Szabo S, Taché Y, Glavin G. Neuroendocrinology of Gastrointestinal Ulceration: Hans Selye Symposia on Neuroendocrinology and Stress. vol. 2:1995;221-230 Plenum Publishing Corporation, New York.
33. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Jurina J., Konjevoda P., Hanzevacki M., Ljubanovic D., Separovic J., Gjurasin M., Bratulic M., Artukovic B., Jelovac N., Buljat G. Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Dig. Dis. Sci. 41:1996;1518-1526.
34. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Gjurasin M., Konjevoda P., Separovic J., Ljubanovic D., Artukovic B., Bratulic M., Tisljar M., Jurina L.J., Buljat G., Miklic P., Marovic A. The beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity. Dig. Dis. Sci. 41:1996;1604-1614.
35. 2 blockers and sucralfate on new vessels and new granulation tissue formation. Gastroenterology. 112:1997;291.
36. Sikiric P., Mazul B., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Jurina L., Konjevoda P., Hanzevacki M., Gjurasin M., Separovic J., Ljubanovic D., Artukovic M., Bratulic M., Tisljar M., Miklic P., Sumajstorcic J. Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Dig. Dis. Sci. 42:1997;661-671.
37. Sikiric P., Mikus D., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Peric J., Konjevoda P., Perovic D., Jurina L., Hanzevacki M., Separovic J., Gjurasin M., Jadrijevic S., Jelovac N., Miklic P., Buljat G., Marovic A. Pentadecapeptide BPC 15, cimetidine, ranitidine, bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats. A model study for cytoprotective studies. Dig. Dis. Sci. 42:1997;1029-1037.
38. G-nitro-L-arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure. Eur. J. Pharmacol. 332:1997;23-33.
39. Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., Perovic D., Simicevic V., Hanzevacki M., Ljubanovic D., Artukovic M., Bratulic M., Tisljar M., Rekic B., Gjurasin M., Miklic P., Buljat G. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats. J. Physiol. (Paris). 91:1997;113-122.
40. Simon L. Esophageal mucosal protection - why do we need a special approach? Mózsik Gy, Pár A, Csomós G, Kitajima M, Kondo M, Pfeiffer C.J, Rainsford K.D, Sikiric P, Szabo S. Cell Injury and Protection in the Gastrointestinal Tract: from Basic Sciences to Clinical Perspectives. 1992;135-147 Akedémiai Kiadó, Budapest.
41. Sugiyama M., Hsu-Chang C.Y., Sato Y., Katamura H., Tsuchiya S. Pathophysiology of bone disorder after total gastrectomy. Nippon-Geka-Gakkai-Zasshi. 89:1988;1410-1413.
42. Szabo S. Dopamine disorder in duodenal ulceration. Lancet. 2:1979;880-882.
43. Szabo S., Neumeyer J.L. Dopamine agonists and antagonists in duodenal ulcer disease. Kaiser C, Kebabian W. ACS Symposium Series 224. 1983;175-196 American Chemical Society Publications, Washington.
44. Szabo S., Vattay P., Scarbrough E., Folkman J. Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am. J. M. 91 (2A):1991;158S-160S.
45. Thompson J., Greeley Jr G.H., Rayford P.L., Twonsed Jr C.M. Gastrointestinal Endocrinology. 1987;McGraw-Hill Book Company, New York.
46. Veljaca M., Pllana R., Lesch C.A., Sanchez B., Chan K., Szabo S., Trier J.S., Brown A., Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology. 88:1985;228-236.
47. Veljaca M., Lech C.A., Pllana R., Sanchez B., Chan K., Guglietta A. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 272:1994;417-422.
48. Veljaca M., Chan K., Guglietta A. Digestion of h-EGF, h-TGF alfa, and BPC 15 in human gastric juice. Gastroenterology. 108:1995;761.
49. Veljaca M., Lesch C.A., Sanchez B., Low J., Guglietta A. Protection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action. Gastroenterology. 108:1995;936.